Treatment outcomes
| Overall | Aspirin+Clopidogrel Group | Aspirin+Ticagrelor Group | P Value | ||
|---|---|---|---|---|---|
| Nonavailable data | 1 | 1 | 0 | ||
| Primary outcome (%) | 22 (9.4) | 14 (9.9) | 8 (8.6) | .822 | |
| Secondary outcomes (%) | |||||
| Ischemic stroke | 17 (7.2) | 10 (7.0) | 7 (7.5) | >.999 | |
| Disabling stroke | 8 (3.4) | 4 (2.8) | 4 (4.3) | .716 | |
| Any death | 4 (1.7) | 3 (2.1)a | 1 (1.1)b | >.999 | |
| Safety outcome (%) | 19 (8.1) | 13 (9.2) | 6 (6.5) | .479 | |
| mRS (%) | .484 | ||||
| 0–2 | 227 (96.6) | 136 (95.8) | 91 (97.8) | ||
| 3–6 | 8 (3.4) | 6 (4.2) | 2 (2.2) | ||
| Medication change (%) | 12 (5.1) | 6 (4.2) | 6 (6.5) | .547 |